Market Data 
Markets
Replies to post #23543 on Nascent Pharma Holdings Inc (NASC)
3 Month Pure CBD vs Full Spectrum Chart
CANB is outperforming CVSI/CWBHF/ELLXF
The market may finally be catching on to what we already know — THC will remain federally illegal
And thus, Full Spectrum CBD Oil will not be eligible for national sales
Pure CBD Oil is the big play in 2020:
https://stockcharts.com/freecharts/perf.php?CANB,CVSI,ELLXF,CWBHF&n=60&O=011000
Sleek
I see that not much has changed, outside of the positive news on the government taking action front. Those signs of movement by Congress is outstanding.
Still seeing references to CANB being a scam stock due to the drop of the stock price over last year.
Still seeing references to CANB going below .01 (remember, 300 shares at .005 to scare someone into selling back in December does not really count)
Still seeing references to how bad of a company CANB must be because of the drop in share price.
The consistent lack of awareness with how sector sentiment shows clear and evident inexperience with investing and the market. The oil industry is a great example of how sentiment (towards oil prices) have a direct and significant influence over the stock price of all oil industry stocks, no matter how good they are with fundamentals. The same holds true for Cannabis. Perform an overlay on the charts of a dozen Cannabis companies (including Canb) and you will see they follow almost the exact same trajectory during the past year. Are we supposed to believe that is all a coincidence?
If only they would make the effort to look at other Cannabis stocks in the sector. Since there is ignorance towards that, here is a little side by side comparison:
CANB
Price on 5/1/2019: $.062
Price today: $.0167
Change: -73.1%
Pretty bad, but wait, this gets better:
CVSI
Price on 5/1/2019: $5.35
Price today: $1.09
Change: -79.6% (greater loss than Canb)
CBD MD (who sponsored pro golfer)
Price on 5/1/2019: $6.25
Price today: $1.11
Change: -82.2% (greater loss than Canb)
CBD Unlimited
Price on 5/1/2019: $.50
Price today: $.0805
Change: -83.9% (greater loss than Canb)
Elixinol
Price on 5/1/2019: $3.18
Price today: $.59
Change: -81.4% (greater loss than Canb)
POTN
Price on 5/1/2019: $.123
Price today: $.03
Change: -75.6% (greater loss than Canb)
HEXO
Price on 5/1/2019: $7.94
Price today: $1.78
Change: -77.6% (greater loss than Canb)
To be fair, we can also add Charlottes Web which is the bellwether of the group:
Charlotte’s Web
Price on 5/1/2019: $19.30
Price today: $8.81
Change: -54.3% (not as bad, but those shareholders are also not feeling too great)
This list can go on and on, with the common similarity being that they are all down 70 – 85%. I am sure it will be pointed that Canb was at .10. Well, the list above only reflects the price on 5/1/19. All of the above stocks were also much higher as well.
Now, the sentiment for the industry is starting to improve (Sleek – thanks for keeping us up to date with the latest news). I have said it before that Canb will at least rise with the group, but will most likely surpass it. If it does not, only then can Canb be called out for being a bad investment.
I have not relinquished any of my position in Canb, just needed a hiatus during the Holidays and after the New Year to focus on other things. In my investing experience I have seen the rewards patience can truly bring. Now that we have news which should uplift the sector, I think we are entering exciting times again. Yea, it sucked that Canb dropped so much. But so did my other Cannabis investments, and it’s certainly not due to their fundamentals as well. And I am sure it sucks for many others who have the stocks listed above, or for those who gave up. I am sure everyone truly appreciates (sarcasm) those who post “I told you that was a bad stock” messages, despite the fact that they never predicted such a significant downturn in the overall sector. However, we have hit the ground floor and are headed up. For those who understand charts, they will notice the bottoming and leveling that took place over the past few months. Not just with Canb, but other stocks as well. proclamations that Canb is going “sub-penny” or “sub-zero” (which is actually impossible) will simply not come true. I look forward to 2020 Q1, which is the first quarter NY Hemp Depot revenues are announced (it was stated in previous filings that Q1 was the first distribution).
It’s comical to still see year old references to CBD isolate being everywhere, that no one wants it, everyone on the Canb BOD being busted scam artists (including a Senator, chosen as majority leader), A CEO who is allegedly busted every couple of years for penny stock scamming (with no proof, outside of a couple FINRA management violations over 13 years ago which have been grossly misinterpreted as “acts of scamming”), the mysterious, scary and ever elusive Redwood, accountants that are committing felonies for Canb by documenting false revenue on SEC filings, printing shares in some back room, handing out shares to everyone in order to drive this sub penny (which I don’t understand, because if you were awarded shares wouldn’t you want the PPS to increase and not decrease?), references to why other CBD oil on Amazon is cheaper and Canb is overcharging (not realizing that the $20 bottle you are getting on Amazon is hemp seed oil and not CBD), and on and on.
There are still numerous references to the retail part of CANB, along with its shortcomings. Those references are intentional to make it seem like that is all CANB has going for it. I like the fact that Canb has gone after full vertical integration. Actually, this article today validates it:
https://seekingalpha.com/article/4316175-cv-sciences-what-went-wrong
To summarize, it indicates CVSI will have a hard road ahead because they only do retail and the competition is killer. Past posts (which included actual factual links) on this board have shown how lucrative hemp cultivation, aggregation and processing is, and the revenue from Canb’s ventures will be announced this quarter. Many, if not all of the other Cannabis companies don’t have this.
My favorite so far is the sub-standard research presented (at least that is one step better than telling people to go do their own research) announcing a big glut in biomass supply that will ruin Canb. This merely shows a significant lack of understanding that it’s a domino effect due to lack of processing (BTW – Canb also does that too) and uncertainty without FDA approval. Also, due to poor farming techniques and farming inexperience producing low CBD content hemp.
https://newfrontierdata.com/marijuana-insights/oversupply-of-u-s-hemp-hampered-by-lack-of-processing-outlets/
https://www.bendbulletin.com/business/hemp-growers-face-tough-challenges/article_f68af8a4-8403-552d-947d-9141f0a1bce3.html
Also, for those articles discussing the oversupply:
https://www.hempbenchmarks.com/supply-chain/hemp-farmers-growing-pains-overproduction/
“Owners blame a massive over-production of hemp and lack of guidance from the FDA, which is creating uncertainty about the legality of CBD in consumer products”
So, when the sideline companies such as Mondalez and Ben & Jerrys that want to make CBD products finally see legalization and need a massive amount of CBD isolate for their products, will the oversupply still exist?
Now my true favorite will always be the allegations against Canb, that were allegedly supported by facts, and those facts were allegedly documented, and were allegedly previously posted and also are allegedly easy to Google, and allegedly easy enough for anyone to see so said allegations don't need to be proven, along with having been allegedly predicted all along.
I stand back, and simply look forward to the future.....
AI
